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Abstract
Expression of the Endothelin-2 (Edn2) mRNA is greatly increased in the photoreceptors (PRs) of mouse models of inherited
PR degeneration (IPD). To examine the role of Edn2 in mutant PR survival, we generated Edn22/2mice carrying homozygous
Pde6brd1 alleles or the Tg(RHO P347S) transgene. In the Edn22/2 background, PR survival increased 110% in Pde6brd1/rd1 mice
at post-natal (PN) day 15, and 60% in Tg(RHO P347S) mice at PN40. In contrast, PR survival was not increased in retinal
explants of Pde6brd1/rd1; Edn22/2 mice. This finding, together with systemic abnormalities in Edn22/2 mice, suggested that
the increased survival of mutant PRs in the Edn22/2 background resulted at least partly from the systemic EDN2 loss of
function. To examine directly the role of EDN2 in mutant PRs, we used a scAAV5-Edn2 cDNA vector to restore Edn2
expression in Pde6brd1/rd1; Edn22/2 PRs and observed an 18% increase in PR survival at PN14. Importantly, PR survival was
also increased after injection of scAAV5-Edn2 into Pde6brd1/rd1 retinas, by 31% at PN15. Together, these findings suggest that
increased Edn2 expression is protective to mutant PRs. To begin to elucidate Edn2-mediated mechanisms that contribute to
PR survival, we used microarray analysis and identified a cohort of 20 genes with .4-fold increased expression in Tg(RHO
P347S) retinas, including Fgf2. Notably, increased expression of the FGF2 protein in Tg(RHO P347S) PRs was ablated in
Tg(RHO P347S); Edn22/2 retinas. Our findings indicate that the increased expression of PR Edn2 increases PR survival, and
suggest that the Edn2-dependent increase in PR expression of FGF2 may contribute to the augmented survival.
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Introduction
IPDs are genetically heterogeneous disorders characterized by
the progressive death of mutant PRs. Although more than 160
IPD-associated genes have been identified in humans, with many
of these mutations modeled in mouse, relatively few studies have
examined the biochemical mechanisms that promote or resist
death in the mutant PR [1,2]. Factors shown to promote the
survival of mutant or injured PRs include IL-6 cytokines
[3,4,5,6,7], STAT3 [8], and neurotrophic factors including
FGF2 [9,10,11,12,13]. In contrast, other molecules including
GFAP and vimentin [14,15], complement factor D [16], TNFa
[17] and poly-ADP-ribose polymerase-1 [18] have been shown to
contribute to the death of mutant or injured PRs.
One gene whose PR expression is strongly induced by PR
mutations is Edn2 [19]. Retinal Edn2 transcripts are up-regulated
in multiple models of photoreceptor degeneration [19,20,21], as
well as in other retina stresses including, for example, retinal
detachment [19,22] and retinal hypoxia [23] amongst others.
These observations suggest that the increased expression of Edn2
may be a general response to retinal insult.
EDN2 is a vasoactive peptide that binds to two G-protein
coupled receptors, EDNRA and EDNRB, with equal affinity [24].
EDNRB is expressed in both Mu¨ller glia [19] and horizontal cells
[25] in neural retina, whereas EDNRA is present in bipolar
dendrites [25]. Both receptors are detected in choroidal and retinal
vessels [26].
The biological roles of EDN2 are the least well-characterized of
the three endothelin family members [27]. EDN2 has been found
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to participate in macrophage chemoattraction in breast tumor cell
invasion [28,29], keratinocyte differentiation [30], and oviductal
contraction during ovulation [31,32]. Within the context of PR
injury, the effect of the increased expression of Edn2 on PR
survival is unclear. Whereas the intravitreal administration of an
EDNRB antagonist increased PR death in one IPD model [5] and
reduced the protective effects of Norrin in light damage [33], the
subcutaneous administration of a dual EDNRA-EDNRB receptor
antagonist after light damage reduced PR layer staining for
cleaved caspase-3, a cell death marker [25].
We used genetic analyses to determine whether the increased
expression of Edn2 in mutant PRs is a pathogenic or a pro-survival
response, in two well-defined mouse models of IPDs, mice carrying
a mutant human rhodopsin transgene (Tg(RHO P347S)) [34]
associated with human PR degeneration, and Pde6brd1/rd1 mice,
with a mutation in the b subunit of the PR-specific phosphodi-
esterase-6 (PDE-6) gene [35]. We over-expressed Edn2 in mutant
PRs and found that it plays a protective role in one model of IPD.
We also provide evidence consistent with this protection being at
least partly mediated by FGF2, a known neuroprotective factor
[9].
Results
Increased expression of the Edn2 mRNA and peptide in
mutant PRs
To confirm that Edn2 transcripts are up-regulated in the
Prph2rds/+, Tg(RHO P347S), and Pde6brd1/rd1 mouse models of IPD
we studied, we measured retinal Edn2 mRNA abundance. As
reported by Rattner and Nathans in other models [19], we found
the Edn2 mRNA to be greatly increased vs. wild-type (WT)
controls in Prph2rds/+ (32-fold), Tg(RHO P347S) (70-fold), and
Pde6brd1/rd1 (72-fold) retinas, using qRT-PCR (for each model
n = 3; p,0.005) (Fig. 1A).
We also confirmed, by in situ hybridization using Prph2rds/+ and
Tg(RHO P347S) mice, the observation of Rattner and Nathans
[19] that the increase in the Edn2 mRNA is PR-specific (Fig. 1B).
To determine if Edn2 mRNA up-regulation is a leading or lagging
indicator of PR death, we examined the temporal up-regulation of
Edn2 mRNA in Pde6brd1/rd1 retinas by qRT-PCR (Fig. 1C,D). The
abundance of the Edn2 transcript in Pde6brd1/rd1 retinas at PN8,
measured as the ratio of Edn2 mRNA:Gapdh mRNA expression,
was comparable to the expression of Edn2 transcripts in WT
retinas at all time points examined (data not shown). By PN10,
however, a statistically significant increase in Edn2 transcripts was
detected in Pde6brd1/rd1 retinas (Fig. 1C,D)(*n = 3, p,0.05 vs. WT
retinas; at this age, pycnotic nuclei are present in this mutant [36]).
The decrease in Edn2 mRNA expression with time (Fig. 1C) is
likely to reflect the decreasing number of PRs in the Pde6brd1/rd1
retina, since the mRNA expression of Edn2 relative to rhodopsin
increases with time (Fig. 1D), indicating that the expression of the
Edn2 mRNA per PR increased as the number of PRs progressively
decreased. Edn2 transcripts remained substantially up-regulated as
late as PN18 (data not shown).
To determine whether the increase in Edn2 transcripts in
mutant retinas is accompanied by increased levels of EDN2
peptide, we quantified EDN2 in Prph2rds/+ retinas by radioimmu-
noassay after separating the EDN2 peptide from EDN1 and
EDN3 by HPLC. The abundance of EDN2 was below the
detection limit in WT retinas (,0.05 fmol/retina; n = 10 retinas),
making it impossible to determine the maximum fold increase in
EDN2 mutant retinas. However, 0.15 fmol/retina (n = 10 retinas)
of EDN2 was detected in Prph2rds/+ retinas, indicating that the
EDN2 peptide is increased by a minimum of three-fold in
Prph2rds/+ retinas.
Retinal expression of components of endothelin
signaling biology
To evaluate whether the large increase in Edn2 expression in
mutant PRs was accompanied by increases in other components of
endothelin biology, we first quantified the expression of the
mRNAs for Edn1, Edn3, EdnrA, and EdnrB in WT and mutant
retinas (Fig. S1). Overall, there were no significant differences at
PN21 between Edn2+/+, Edn22/2, Tg(RHO P347S);Edn2+/+ and
Tg(RHO P347S);Edn22/2 retinas in the expression of these genes
(all n = 3, p.0.05) (Fig. S1), with one exception: the mRNA of
EdnrA in Tg(RHO P347S);Edn22/2 was modestly increased, by 2.3-
fold, compared to Edn2+/+ retinas (n = 3, p,0.05) (Fig. S1).
EDN2 is processed from a prepro peptide that undergoes
sequential cleavage events to generate mature EDN2 (mat EDN2)
(Fig. 4B). To determine where endothelin-converting enzyme 1
(ECE-1), an enzyme implicated in the processing of big EDN2 to
mature EDN2 [37], is expressed in retina, we used immunoflu-
orescence staining. We found that ECE-1 was expressed in Mu¨ller
cell bodies and radial fibres (Fig. S2A), as shown by comparison
with the Mu¨ller cell-specific marker glutamine synthetase [38].
To determine whether the expression pattern of the EDNRA
and EDNRB receptors was altered in Pde6brd1/rd1 retinas, in the
presence or absence of Edn2 expression, we used immunofluores-
cence staining (Fig. S2B). In mice of all four genotypes, EDNRA
expression was low, with only scattered staining in the choroid,
OPL, INL and GCL, which may represent retinal microglia (42)
that migrate to the mutant PRs in the ONL [39]. There was no
significant difference in EDNRA staining in Pde6brd1/rd1; Edn2+/+
vs. Pde6brd1/rd1; Edn22/2 retinas (Fig. S2B).
EDNRB expression in WT retina was seen predominantly in
the outer plexiform layer (OPL) as well as in cells, possibly
astrocytes, in the GCL (Fig. S2B). In the Pde6brd1/rd1 retina,
EDNRB expression in the Pde6brd1/rd1 retina was increased
throughout Mu¨ller cell radial fibres, with stronger staining in the
inner limiting membrane (ILM), which contains the end feet of
Mu¨ller cells. In contrast to the OLM staining observed in light-
damaged retinas [19], no outer limiting membrane (OLM)
staining of ENDRB was detected in the Pde6brd1/rd1 retina.
EDNRB expression remained increased in the absence of EDN2
in the Pde6brd1/rd1; Edn22/2 retina (Fig. S2B), indicating that the
up-regulation of EDNRB expression in the mutant retina is not
EDN2-dependent.
A simple model consistent with the expression pattern of the
endothelin receptors and converting enzyme in the PR mutant
retina is therefore that big EDN2 produced in mutant PRs is
released into the PR extracellular space, and converted to mat
EDN2 by the extracellular moiety of ECE-1 [40] located on
Mu¨ller cell radial fibres that surround the PRs. The mat EDN2
could then bind to EDNRB, also located on Mu¨ller cell radial
fibres.
EDN2 loss of function increases PR survival in vivo, but
not ex vivo
To determine whether EDN2 promotes, resists, or has no
influence on PR survival in IPDs, we used Edn22/2 mice to
generate Tg(RHO P347S); Edn22/2 and Pde6brd1/rd1; Edn22/2
animals. We first determined that EDN2 is not required for
normal retinal or PR formation or survival by examining the
morphology of adult Edn22/2 retinas. No significant difference in
gross morphology, or in ONL thickness (n = 5; p.0.05), was
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observed between WT and Edn22/2 retinas at PN40 (Fig. 2A).
Edn22/2 mice were born at normal Mendelian ratios but
exhibited runting by PN7 and a survival rate of only 25% at
PN20 (unpublished observations). Edn2+/2 mice displayed no
overt phenotype. To allow observation of the effects of EDN2 loss
in the slower degenerating Tg(RHO P347S) retinas, we were able
to extend the lifespan of Edn22/2 mice to a maximum of PN50 by
using a liquid diet and daily subcutaneous injections of normal
saline to maintain fluid and electrolyte balance.
Remarkably, the loss of EDN2 function led to dramatically
increased PR survival in both Pde6brd1/rd1 and Tg(RHO P347S)
mice. At PN15, the thickness of the ONL increased by 110% in
Pde6brd1/rd1; Edn22/2 vs. Pde6brd1/rd1; Edn2+/+ retinas at PN15
(n = 6; p,0.05) (Fig. 2B), and by 63% in Tg(RHO P347S);
Figure 1. Retinal Edn2 mRNA is increased in several models of IPD. (A) qRT-PCR assays of the Edn2 mRNA. Edn2 was increased 32-fold, 70-
fold, and 72-fold in the Prph2rds/+ (7 weeks), Tg(RHO P347S) (3 weeks) and Pde6brd1/rd1 (PN12) models of IPD, respectively (**n = 3; Student’s t-test
p,0.005). At the three time points chosen, .40% of the PR population remained. Edn2 mRNA expression was assigned a value of 1 in WT retinas, to
calculate its relative expression in the IPD models. qRT-PCR values were normalized to the mRNA expression of Gapdh. (B) In situ hybridization of Edn2
mRNA in Prph2rds/+ and Tg(RHO P347S) retinas. Edn2 transcripts were undetectable in WT retina, but were detected exclusively in the ONL of the
mutant PRs (arrowheads) in Prph2rds/+ and Tg(RHO P347S) retinas. (C,D) Temporal expression of Edn2 transcripts during PR degeneration in Pde6brd1/rd1
retinas, relative to WT Edn2 mRNA expression at PN12 and normalized to Gapdh mRNA (C), or rhodopsin mRNA (D). Edn2 mRNA was not significantly
increased until PN10 (*n = 3; p,0.05 vs. WT). RPE, retinal pigment epithelium; ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell
layer. Error bars indicate SEM; scale bar = 10 mm.
doi:10.1371/journal.pone.0058023.g001
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Figure 2. The effect of EDN2 loss on mutant PR survival in vivo and in retinal explants. (A) At PN40, the histology and the thickness of the
ONL (n = 5;p.0.05) was normal in toluidine-blue stained Edn2+/+ and Edn22/2 retinas. (B,C) The loss of EDN2 in Tg(RHO P347S) retinas resulted in a
mean 63% increase in ONL thickness at PN40 (n = 6; p,0.005) (C) and a mean 110% increase in ONL thickness in Pde6brd1/rd1 retinas at PN15 (n = 6;
p,0.005) (B). (D) ONL thickness in WT, Pde6brd1/rd1 and Tg(RHO P347S) retinas in mice expressing or lacking EDN2 (**p,0.005). (E) qRT2PCR assays of
the Edn2 mRNA, normalized to Gapdh mRNA, in in vivo WT, WT explants and Pde6brd1/rd1 explants (n = 3;*p,0.05). Values were compared to the mean
Edn2 mRNA levels in WT in vivo samples (arbitrarily given a value of 1). Edn2 transcripts were significantly increased in WT as well as Pde6brd1/rd1
explants at PN12 following retinal dissection at PN7, likely as a result of dissection-induced mechanical stress. (F) WT retinal explants cultured ex vivo
from PN7-PN17 had an average of 7–8 rows of PR nuclei at PN17 (n = 10 retinas, one representative shown). Owing to artifacts in frozen sections, the
number of nuclei, instead of ONL thickness, was assessed in retinal explants. The absence of EDN2 in Pde6brd1/rd1; Edn22/2 retinal explants did not
increase PR survival. Both Pde6brd1/rd1 and Pde6brd1/rd1; Edn22/2 explants cultured from PN7-PN17 had an average of 3 rows of PR nuclei at PN17
(n = 4;p.0.05, one representative shown) (H&E staining). ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. (Black bar = 25 mm
in A–C, and F). Error bars indicate SEM.
doi:10.1371/journal.pone.0058023.g002
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Edn22/2 vs. Tg(RHO P347S); Edn2+/+ retinas at PN40 (n = 6;
p,0.05) (Fig. 2C). The increased PR survival was not due to a
compensatory change in the expression of Edn1 and Edn3 mRNAs
due to the absence of EDN2 in Edn22/2 retinas, because the
abundance of these two mRNAs in Edn22/2 retinas was not
significantly different from WT (Fig. S1). In summary, these
findings indicate that the systemic loss of EDN2 in mouse models
of IPD strongly protects PRs from death (Fig. 2D).
To separate the effects of increased retinal Edn2 in Pde6brd1/rd1
retinas from potentially confounding systemic Edn22/2 pheno-
types, such as hypoxia (see below), we examined the impact of
EDN2 loss on PR death in an ex vivo retinal explant system.
Pde6brd1/rd1 retinas were used for the retinal explant assays because
they recapitulate, in the explant, the PR death seen in the
Pde6brd1/rd1 mouse (40), manifesting substantial PR death well
before the explant is no longer viable (at four weeks in culture).
Retinas were removed from mice sacrificed at PN7, well before the
onset of PR degeneration [36] and, owing to a slightly slower rate
of degeneration ex vivo, examined at PN17. qRT-PCR measure-
ments of Edn2 transcripts in retinal explants showed that Edn2
mRNA is induced both in WT and Pde6brd1/rd1 retinal explants at
PN12 (Fig. 2E). The induction of Edn2 mRNA in WT explants was
anticipated, since Edn2 transcripts are induced as a result of retinal
detachment [19], and retinal dissections are associated with
substantial mechanical stress. WT retinas cultured from PN7 until
PN17 had 7–8 rows of PRs at PN17 (n = 6), as expected [41]
(Fig. 2F). In contrast to the increased survival of mutant PRs
observed in Pde6brd1/rd1; Edn22/2 and Tg(RHO P347S); Edn22/2
retinas in vivo, the absence of EDN2 had no effect on PR survival in
Pde6brd1/rd1; Edn22/2 retinal explants: both Pde6brd1/rd1 and
Pde6brd1/rd1; Edn22/2 explants had 4–5 rows of PRs at PN16
(data not shown) and 2–3 rows of PRs at PN17 (Fig. 2F) (n = 6;
p.0.05). Consequently, the fact that the rate of PR death in
Pde6brd1/rd1; Edn22/2 retinas is slowed in vivo but not in retinal
explants suggests the possibility that the increased PR survival seen
in vivo may be partly or entirely due to extra-ocular effects of the
loss of EDN2 function.
Hypoxia as one mechanism for PR protection in
Pde6brd1/rd1; Edn22/2 and Tg(RHO P347S); Edn22/2 mice
To identify possible systemically-mediated causes of the
increased in vivo survival of PRs in Tg(RHO P347S); Edn22/2
and Pde6brd1/rd1; Edn22/2 retinas, we examined Edn22/2 mice for
gross morphological abnormalities. Among other phenotypes, we
found that Edn22/2 mice have defective lungs leading to systemic
hypoxia (unpublished data). The hypoxia was associated with an
11-fold increase in erythropoietin (EPO) levels at PN21 (n = 7;
p,0.05)(Fig. 3A). Moreover, vascular endothelial growth factor
(VEGF) levels in Edn22/2 retinas were 4.2-fold elevated (n = 4;
p,0.05), an increase consistent with the presence of retinal
hypoxia (Fig. 3B). The presence of systemic and probable retinal
hypoxia in Edn22/2 mice suggests that hypoxia may be at least
partially responsible for the increased in vivo PR survival in
Pde6brd1/rd1; Edn22/2 and Tg(RHO P347S); Edn22/2 retinas, since
we have previously demonstrated that hypoxia increases PR
survival in Pde6brd1/rd1 retinal explants [42].
Over-expression of Edn2 in PRs increases their survival in
Pde6brd1/rd1 mice
To examine directly the role of increased Edn2 expression in
mutant PRs, we introduced an Edn2 cDNA into Pde6brd1/rd1 and
Pde6brd1/rd1; Edn22/2 retinas using the scAAV5-smCBA vector
[43]. Due to the low survival rate of Edn22/2 mice, we performed
the scAAV5 experiments in Pde6brd1/rd1 mice. We initially
confirmed the PR expression of this vector by assessing the spatial
and temporal expression of GFP from a scAAV5-smCBA-Gfp
(AAV-Gfp) vector in frozen sections (Fig. 4A, panels 1–4). Using
paraffin sections, GFP staining was observed in PR nuclei, as
reported by others [43] (Fig. 4A, panel 5). AAV-Gfp was injected
subretinally on PN8 and GFP expression examined on PN10,
PN12 and PN14 (Fig 4A). PR expression of GFP was evident
throughout the ONL and retinal pigment epithelium (RPE), with
the highest expression adjacent to the injection site (Fig 4A, arrow)
and in half of the retina extending from the optic disc to periphery
(data not shown). Minimal GFP staining was seen two days post-
injection, with significantly stronger expression at PN12 and PN14
(Fig. 4A), an increase comparable to the observed temporal
increase in the endogenous Edn2 transcript in Pde6brd1/rd1 retinas
Figure 3. Systemic erythropoietin (EPO) and retinal vascular endothelial growth factor (VEGF) is increased in Edn22/2mice. At PN21,
serum EPO was increased 11-fold in Edn22/2 vs. Edn2+/+ mice (n = 7; p,0.005) (A) and retinal VEGF was increased 4-fold (n = 4; p,0.005) (B). EPO and
VEGF were both measured using ELISA assays. Error bars indicate SEM.
doi:10.1371/journal.pone.0058023.g003
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(Fig. 1C,D). In subsequent studies, we therefore introduced the
AAV vectors at PN8, to assure strong expression by PN12 and
later.
To establish that robust retinal expression of a cDNA encoding
mature EDN2 could be obtained from a scAAV5-smCBA-matEdn2
vector (AAV-matEdn2), we injected it into Pde6brd1/rd1 retinas at
PN8. At PN12, expression of the mature Edn2 mRNA was 2.5- to
11.3-fold greater (mean 6.9-fold; n = 4) than the level of the
endogenous Edn2 mRNA in Pde6brd1/rd1 retinas (Fig. 4C, left bar).
Similarly, we quantified the expression of a prepro Edn2 cDNA
from an scAAV5-smCBA-preproEdn2 (AAV-preproEdn2) vector.
Any difference between outcomes in PR survival using the
matEdn2 vs. the preproEdn2 vectors could suggest that the
processing of prepro EDN2 to mat EDN2 is rate-limiting. We
found that expression of the prepro Edn2 mRNA was 1.7- to 7.2-
fold (average 4.3-fold; n = 4) greater than the level of the
endogenous Edn2 mRNA in Pde6brd1/rd1 retinas (Fig. 4C, right
bar). In summary, in Pde6brd1/rd1 retinas both the AAV-matEdn2
and the AAV-preproEdn2 vectors expressed their respective
mRNAs at levels on average 4.3- to 6.9-fold above the expression
level of the native Edn2 mRNA.
To examine the role of the increased PR expression of Edn2 on
PR survival in IPD, we augmented the endogenous increase in
Edn2 expression in PRs in Pde6brd1/rd1 mice using AAV vectors
Figure 4. Expression of GFP and Edn2 from subretinally injected scAAV5. (A) The temporal and spatial expression of GFP in WT retinas
injected subretinally with 1X PBS or scAAV5-smCBA-Gfp at PN8 and evaluated at PN10, PN12, and PN14 by GFP immunofluorescence (A, Panels 1–4).
Significant GFP staining was not observed until PN12, with stronger staining at PN14, especially in the vicinity of the subretinal injection site (arrow).
The spatial expression of GFP in WT retinas injected with scAAV5-smCBA-Gfp was also evaluated in paraffin sections at PN12 (A, Panel 5). GFP
expression was observed predominantly in the ONL and RPE; sporadic expression of GFP in Mu¨ller cells was also observed in paraffin sections.
(Bar = 25 mm.) (B) Schematic of the EDN2 cleavage events required to produce the mature EDN2 peptide. EDN2 is first produced as prepro EDN2 (175
aa) which is rapidly processed by furin-like endopeptidases to yield big EDN2 (38 aa). Big EDN2 must then be cleaved by an endothelin-specific
converting enzyme (ECE) to produce the 21 a.a. mature EDN2 peptide that can bind to endothelin receptors (figure adapted from [68]). The regions of
the Edn2 mRNA corresponding to the cDNAs cloned into the scAAV5-smCBA-preproEdn2 and scAAV5-smCBA-matEdn2 vectors are shown. (C)
Expression of scAAV5-derived Edn2 mRNA in Pde6brd1/rd1 retinas at PN12 after injection of the scAAV5-smCBA-preproEdn2 and scAAV5-smCBA-
matEdn2 constructs at PN8. scAAV5-derived Edn2mRNA expression values are shown relative to the levels of endogenous Edn2mRNA (from the same
retina) and all values were normalized to Gapdh. scAAV5-preproEdn2 transcripts were increased between 1.7 and 7.2-fold (n = 4; average 4.3-fold) over
endogenous Edn2 mRNA, while scAAV5-matEdn2 transcripts increased between 2.5 to 11.3-fold over the endogenous Edn2 mRNA (n= 4; average 6.9-
fold). ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. Error bars indicate SEM.
doi:10.1371/journal.pone.0058023.g004
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(Fig. 5). We used 1X PBS injection as the control injection in the
contralateral eye, because when we compared ONL thickness in
1X PBS injected retinas to AAV-Gfp injected Pde6brd1/rd1 retinas,
we observed no difference. The introduction of AAV-matEdn2 at
PN8 in WT retinas did not alter PR morphology or survival at
PN15 (n = 6; p.0.05) (Fig. 5A(a)). Remarkably, the injection of
AAV-matEdn2 increased retinal ONL thickness in Pde6brd1/rd1
retinas at PN15 by 31% (n = 9; p,0.05) compared to the injection
of 1X PBS in the contralateral eye (Fig. 5A(b)). In contrast, the
AAV-preproEdn2 vector failed to improve PR survival in Pde6brd1/
rd1 retinas (n = 6; p.0.05) (Fig. 5A(d)), Fig. 5B), suggesting that
ECE enzyme sites may be saturated in this context, in which the
endogenous increase in Edn2 expression is combined with the
production of prepro Edn2 from the AAV vector. We also restored
the PR expression of Edn2 in Pde6brd1/rd1; Edn22/2 mice using the
AAV vectors. In this instance, the injection of either the matEdn2
or preproEdn2 vectors increased ONL thickness at PN14 and
PN15, by 18% (n = 5; p,0.05) (Fig. 5A(c)) and 14% (n = 6;
p,0.05) (Fig. 5A(e)), respectively. The effects of the AAV vectors
on PR survival are summarized in Fig. 5B. Overall, these findings
provide evidence that the increase in Edn2 expression is a
protective response that increases the survival of mutant PRs, at
least in Pde6brd1/rd1 retinas.
Figure 5. scAAV5-mediated transfer of the mature Edn2 cDNA at PN8 increases mutant PR survival. (A) Micrographs showing ONL
thickness in individual retinas at PN14–15. (a) Injection of the scAAV5-smCBA-matEdn2 vector into WT retinas at PN8 did not alter retinal morphology
at PN15. (b) Injection of the scAAV5-smCBA-matEdn2 vector at PN8 increased PR ONL thickness of Pde6brd1/rd1 retinas by 31% (n= 9; *p,0.05) at PN15,
and (c) of Pde6brd1/rd1; Edn22/2 retinas at PN14 by 18% (n= 5; *p,0.05). (d) In contrast, injection of the scAAV5-smCBA-preproEdn2 vector at PN8 had
no effect on PR ONL thickness of Pde6brd1/rd1 retinas (n = 6;p.0.05) at PN15, although (e) this vector improved PR survival in Pde6brd1/rd1; Edn22/2
retinas by 14% (n= 6; *p,0.05). (B) A bar graph summarizing the effects of AAV vectors expressing Edn2 cDNAs, injected at PN8, on mutant PR
survival in Pde6brd1/rd1 and Pde6brd1/rd1; Edn22/2 retinas at PN14–15. ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. (Black
bar = 25 mm). Error bars indicate SEM.
doi:10.1371/journal.pone.0058023.g005
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Evidence that EDN2-mediated up-regulation of FGF2
expression is a survival response
To identify retinal genes whose expression is directly or
indirectly regulated by EDN2 in the presence of the Tg(RHO
P347S) mutant allele, we identified mRNAs that were differentially
expressed in Tg(RHO P347S); Edn2+/+ vs. Edn2+/+ retinas, to
mRNAs that were differentially expressed between Tg(RHO
P347S); Edn22/2 vs. Edn22/2 retinas (Fig. 6). This comparison
was used, rather than contrasting the mRNAs of Tg(RHO P347S);
Edn2+/+ vs. Tg(RHO P347S); Edn22/2 retinas, because this latter
comparison would fail to distinguish between mRNA changes due
the absence of EDN2 alone and indirect changes due to the
absence of EDN2 in the presence of the Tg(RHO P347S) mutant
allele.
The mRNA populations were examined using Mouse 430_2.0
Affymetrix arrays (two retinas from one mouse/array, four arrays/
genotype). Retinal mRNA was collected at PN21, three days after
the onset (at PN18) of Edn2 mRNA expression in Tg(RHO P347S)
retinas (data not shown). Transcripts with a .2.0-fold difference in
expression in these two comparisons (p,0.05 using a two class
unpaired t test) are shown in Figure 6.
The 20 genes whose expression was most induced (.4-fold;
p,0.05) in Tg(RHO P347S); Edn2+/+ vs. Edn2+/+ retinas were also
induced in Tg(RHO P347S); Edn22/2 vs. Edn22/2 retinas (Fig. 6).
Notably, the expression of all 20 of these Tg(RHO P347S)-induced
genes was down-regulated in Tg(RHO P347S); Edn22/2 retinas
(Fig. 6). This finding suggests that EDN2 may have broad effects
on the transcription of a cohort of retinal genes (including the 20
genes shown in Fig. 6), a cohort that respond to the presence of a
PR mutation, in this instance the Tg(RHO P347S) transgene.
Of the 20 genes whose expression is most reduced by the loss of
EDN2, only Fgf2 [9,44,45] has been shown to increase PR survival
in IPDs, and only the loss of Gfap has been demonstrated to
attenuate PR death due to retinal injury [14]. To investigate the
role of Fgf2 and Gfap in the response of the Tg(RHO P347S) retina
to the loss of EDN2 function, we first used qRT-PCR to confirm
and to quantify the decrease in the expression of Fgf2 and Gfap in
Tg(RHO P347S); Edn22/2 retinas compared to Tg(RHO P347S);
Edn2+/+ retinas (Fig. 7A). We also quantified the expression of
Gm12541 because the microarray analyses indicated that the
dramatic increase in Gm12541 expression in Tg(RHO P347S);
Edn2+/+ retinas was reduced in Tg(RHO P347S); Edn22/2 retinas
(Fig. 6). The qRT-PCR analyses confirmed remarkable increases
in the expression of Edn2 and Gm12541 in Tg(RHO P347S); Edn2+/+
vs. Edn2+/+ retinas (70.3- and 29.8-fold respectively), as well as a
substantial increase in Fgf2 and Gfap expression (3.0- and 2.0-fold
respectively; Fig. 7A). In the absence of EDN2 in Tg(RHO P347S);
Edn22/2 retinas, the expression of Gm12541, Fgf2 and Gfap
decreased significantly (from 1.6–2.6 fold;Fig. 7A).
We then used FGF immunostaining to ask whether expression
of the FGF2 protein was also increased in Tg(RHO P347S) retinas,
in the presence and absence of EDN2, and whether the increase
occurred in the mutant PRs or other retinal cell types (Fig. 7B).
Low levels of FGF2 expression were detectable in all three nuclear
layers of both Edn2+/+ and Edn22/2 retinas (Fig. 7B). In Tg(RHO
P347S); Edn2+/+ retinas, FGF2 expression was strongly up-
regulated, predominantly in PRs (Fig. 7B). In contrast, the
increase in the PR FGF2 expression was abolished in the Tg(RHO
P347S); Edn22/2 retina (Fig. 7B), demonstrating that EDN2
directly or indirectly regulates the induction of PR FGF2
expression induced by the Tg(RHO P347S) mutation. Altogether,
these findings establish that the increased expression of both the
Fgf2 mRNA and the FGF2 protein in the mutant retina are largely
dependent on the expression of EDN2.
An increase in the Mu¨ller cell expression of GFAP was also
observed in the Tg(RHO P347S); Edn2+/+ retina, as has been
reported in other IPDs [19,46] (Fig. 7B). GFAP expression in
Mu¨ller cells decreased significantly in the Tg(RHO P347S);
Edn22/2 retina, although not entirely, indicating that the
expression of GFAP in Mu¨ller cells in the mutant retina is partly
regulated, directly or indirectly, by EDN2 (Fig. 7B).
Discussion
Increased PR Edn2 expression appears to be a survival
response
We have shown that Edn2 mRNA is induced in Prph2rds/+,
Tg(RHO P347S), and Pde6brd1/rd1 retinas at early stages of mutant
PR degeneration. This finding, combined with those of Rattner
and Nathans [19], and others [5,47], establish that the greatly
increased expression of Edn2 is a common and possibly general
response of PRs (including cones [5]) to the presence of an IPD
mutation in either the PRs or in the RPE [21], and is elicited even
though the mutations affect proteins with widely diverse functions.
The increased PR expression of Edn2 appears to be an early
response imposed by a mutation [19] or other insults, including
mechanical and light damage [19,20], rather than an event in a
death-signaling cascade, because the increase occurs early in
mutant PRs, the majority of which will not die for weeks to months
after birth, at least in the Prph2rds/+ and Tg(RHO P347S) models.
Using the Pde6brd1/rd1 model mouse, we have presented two lines
of evidence that the increased expression of Edn2 in mutant PRs is
a survival response. First, augmentation of the endogenous
increase in Edn2 expression in the Pde6brd1/rd1 mouse with the
AAV-matEdn2 cDNA vector improved PR survival, by 31%
between PN8 and PN15. Second, the restoration of Edn2
expression with either the AAV-matEdn2 or AAV-preproEdn2
vectors enhanced PR survival in Pde6brd1/rd1; Edn22/2 retinas by
14–18%. Although not large, this latter increase is notable,
because it is additive to the enhanced PR survival that we
identified in the systemic absence of EDN2 function, in
Pde6brd1/rd1; Edn22/2 mice in vivo. The increased survival are also
notable given that the rate of PR death in Pde6brd1/rd1 retinas is the
most rapid of all IPD models, with the great majority of PRs being
ablated by PN21 [48].
Although the 31% increase in PR survival in Pde6brd1/rd1 mice
observed using the AAV-matEdn2 cDNA vector is modest, we
suggest that this finding is important. First, it provides the initial
evidence that Edn2 gene transfer can improve mutant PR survival.
Second, the rate of PR death in the Pde6brd1/rd1 retina is much
more rapid than any other mouse model known; the biological
insult to the PR is extreme.
The improved PR survival observed with AAV-Edn2 gene
transfer suggests future studies to determine if even greater survival
can be obtained by additional enhancement of the EDN2 signaling
pathway. For example, since the conversion of prepro EDN2 to
mat EDN2 by ECEs may be the rate-limiting step in controlling
the availability of EDN2, AAV-mediated transfer of the ECE-1
cDNA may increase mutant PR survival. The possibility that
ECE-mediated cleavage of big EDN2 (Fig. 4B) is the rate-limiting
step in the formation of EDN2 is supported by the finding of
Telemaque et al. [49], who found that increased systemic blood
pressure following adenovirus-mediated over-expression of prepro
EDN1 required the co-injection of an ECE-1 expression construct.
Other strategies to augment EDN2 signaling should also be
examined, such as the use of agonists of the EDN2 signaling
pathway to increase the response to EDN2. For example, the
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administration of an EDNRB agonist in light damaged retinas has
been shown to reduce the number of dying cells [5].
A role for Edn2-dependent increased FGF2 expression in
mutant PR survival
The mechanism by which EDN2 mediates its protective effect
in mutant PRs remain to be elucidated. One starting point for
mechanistic analysis will be to define the roles of the 20 genes we
Figure 6. Identification of possible EDN2 regulated genes using microarrays. Gene expression was examined using the Mouse 430_2.0
Affymetrix array (4 arrays/genotype) and the 20 most differentially expressed mRNAs in Tg(RHO P347S); Edn2+/+ vs. Edn2+/+ retinas, and in Tg(RHO
P347S); Edn22/2 vs. Edn22/2 retinas, at PN21 are shown. All differentially expressed genes in Tg(RHO P347S); Edn2+/+ retinas showed a significant
reduction in expression in Tg(RHO P347S); Edn22/2 retinas, with the exception of Nuclear protein 1. The fold reduction is shown to the right of each
pair of bars. The detection of Edn2 transcripts in Tg(RHO P347S); Edn22/2 retinas is due to the expression of partial Edn2 mRNAs from the Edn22/2
locus, in which part of exon 1 and all of exon 2 were replaced with the Neo cassette. n.s. = no statistically significant increase in expression.
doi:10.1371/journal.pone.0058023.g006
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found to have a .4-fold increased expression in Tg(RHO P347S)
retinas, including Fgf2. We have shown that the increased
expression of Fgf2 may be EDN2-dependent. First, we found that
Fgf2 mRNA in whole retina is 3-fold increased in Tg(RHO P347S)
mice compared to WT mice. This increase did not occur in the
absence of EDN2 in Tg(RHO P347S); Edn22/2 retinas. Second,
we demonstrated, that FGF2 immunolabelling was increased in
Tg(RHO P347S) PRs, but not in the absence of EDN2 in Tg(RHO
P347S); Edn22/2 PRs.
Figure 7. FGF2 expression in Tg(RHO P347S) PRs returns to WT levels in the absence of EDN2. (A) qRT-PCR quantification of Edn2, Gm12541,
Fgf2 and Gfap expression in Tg(RHO P347S) retinas in the presence or absence of EDN2 function. Bar graphs show the expression of mRNAs in retinas of
the indicated genotypes relative to the expression levels seen in Edn2+/+ (WT) retinas. Fold down-regulation in Tg(RHO P347S); Edn22/2 retinas vs. Tg(RHO
P347S); Edn2+/+ retinas is shown to the right of the vertical bars (n = 3;p,0.05 for all mRNAs). All qRT-PCR values were normalized to Gapdh mRNA. ND
(not detected). (B) Immunostaining for FGF2 showed low levels of expression in all three retinal nuclear layers in Edn2+/+ and Edn22/2 retinas, but FGF2
expression increased significantly in the PRs of Tg(RHO P347S); Edn2+/+ retinas at PN21 (third top panel). In contrast, FGF2 staining was similar to WT
retinas in Tg(RHO P347S); Edn22/2 retinas and, most notably, from PRs (fourth upper panel). GFAP expression in Mu¨ller cells was increased in Tg(RHO
P347S); Edn2+/+ retinas (third bottom panel), but reduced in Tg(RHO P347S); Edn22/2 retinas (fourth bottom panel). GFAP expression in Tg(RHO P347S);
Edn22/2 retinas was higher than in Edn2+/+ retinas. ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. (Bar = 25 mm). Error bars
indicate SEM.
doi:10.1371/journal.pone.0058023.g007
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Other evidence supports our proposal that the protective effect
of increased Edn2 expression in mutant PRs is due, at least in part,
to the Edn2-dependent increase in the expression of PR FGF2.
First, exogenous FGF2 is an established survival factor for mutant
PRs [9,45]. Second, like Edn2, retinal Fgf2 transcripts are induced
under conditions of both genetic and environmental PR injury
[50]. Third, Fgf2 mRNA [51] and FGF2 protein expression is
increased in Mu¨ller cells [52] in models of PR injury, and
increased FGF2 immunofluorescence has been observed in PR cell
bodies after optic nerve section. This increase may represent
increased FGF2 expression, increased binding of FGF2 to FGFR1
[53], or both. Fourth, intravitreal administration of an EDNRB
agonist increases Fgf2 mRNA levels in whole WT retina, also
consistent with FGF2 being part of an EDN2/EDNRB signaling
pathway [5]. Finally, EDN1, which exhibits the same selectivity of
binding to endothelin receptors as EDN2, is known to induce Fgf2
mRNA expression in vascular smooth muscle cells [54]. Our data
highlights a putative EDN2/EDNRB/FGF2 signaling pathway
that may be downstream of leukemia inhibitory factor (LIF)-
activated signals. A key role for LIF has been identified in PR
survival in response to retinal insult. LIF was found to be necessary
for the up-regulation of the Edn2 and Fgf2 mRNAs and for
increased PR survival in both rhodopsin VPP mutant retinas [5]
and light-damaged retinas [4]. Furthermore, intravitreal injection
of recombinant LIF into Lif2/2 retinas strongly induced the
expression of Edn2. Since Lif is expressed in a subset of Mu¨ller glia
in response to PR injury [5], we propose that one PR survival
pathway may involve Mu¨ller cell-derived LIF induction of PR
EDN2, which then binds to EDNRB on Mu¨ller cells; an as yet
unidentified Mu¨ller cell signal then acts on the PRs to increase
FGF2 expression. LIF signaling is mediated through gp130, and
PR gp130 has been shown to contribute to PR survival in VPP
retinas [55], indicating that PR gp130 may also be a component of
the EDN2/EDNRB signaling pathway. Recent work by Braunger
et al. suggests that EDN2 may participate in more than one PR
survival pathway, depending on the upstream stimulus. In a light
damage model, PR protection mediated by the over-expression of
Norrin, a Wnt/B-catenin signaling molecule, was also found to be
dependent on EDN2/EDNRB signaling [33]. In this model,
however, the authors concluded that a LIF/EDN2/FGF2
signaling pathway was likely not associated with the protective
effects against light damage observed in Rpe65-Norrin-2 trans-
genic animals. Taken together, the data suggest that EDN2
signaling may participate in the PR response to retinal injury via
multiple survival pathways, including a LIF-independent Norrin-
activated pathway and a LIF- and FGF2-dependent pathway.
It is noteworthy that three of the genes whose expression
decreased the most in Tg(RHO P347S) retinas in the absence of
EDN2: Fgf2, Gm12541 and Nudt6, are all located and overlap on
mouse chromosome 3. Fgf2 is sandwiched between Gm12541 and
Nudt6, which are transcribed from the opposite DNA strand from
Fgf2. Gm12541 overlaps the coding region of Fgf2 at its 59 end, and
Nudt6 overlaps the 39 UTR of Fgf2 at its 39 end. This arrangement,
together with the coordinate expression of these three genes in the
Tg(RHO P347S) retina, suggests that regulatory relationships may
exist between them. Indeed, the mRNA of Nudt6 is a known Fgf2
antisense transcript (Fgf2-AS) that inhibits Fgf2 expression [56,57].
The Gm12541 gene predicts a hypothetical protein, but it may also
be a non-coding RNA that acts as an Fgf2 regulatory antisense
transcript. Some natural antisense transcripts regulate their sense
partners positively, whereas others are negative regulators [58,59].
A variety of regulatory models involving Fgf2, Nudt6 and Gm12541
could account for our finding that the expression of these three
genes is coordinately regulated in the Tg(RHO P347S) retina.
Systemic loss of EDN2 function also increases the survival
of mutant PRs
In addition to the enhanced PR survival observed with AAV-
mediated transfer of the matEdn2 gene to mutant PRs, we also
found that systemic loss of EDN2 function was also protective to
PRs. We propose that the increased PR survival in Pde6brd1/rd1;
Edn22/2 retinas in vivo (vs. in explants) is not due to the loss of PR
Edn2 expression from mutant PRs because i) the restoration of PR
Edn2 expression using either the AAV-matEdn2 or AAV-
preproEdn2 vectors enhanced PR survival in Pde6brd1/rd1;
Edn22/2 mice, rather than accelerating PR death; and ii) PR
survival was not increased in Pde6brd1/rd1; Edn22/2 retinal
explants, consistent with the increased survival observed in
Pde6brd1/rd1; Edn22/2 retinas in vivo being due to extraocular
mechanisms.
We propose that the pulmonary abnormalities and consequent
systemic hypoxia of Edn22/2 mice (unpublished data), perhaps
together with other changes due to the systemic loss of Edn2
expression, may be responsible for the increased in vivo PR survival
in Pde6brd1/rd1; Edn22/2 and Tg(RHO P347S); Edn22/2 mutant
retinas. A role for hypoxia in the increased PR survival is
supported by our finding of increased serum EPO and increased
retinal VEGF levels in Edn22/2 mice, and by our previous
demonstration that the maintenance of Pde6brd1/rd1 retinal explants
in 6% O2 increased PR survival [42]. Moreover, Grimm et al. [60]
found that preconditioning mice in 6% O2 up-regulated retinal
EPO, VEGF and FGF-2 and fully protected PRs from light
damage. In addition, systemic EPO administration has been
shown to increase PR survival in response to both light damage or
IPD mutations [60,61]. Increased retinal VEGF expression may
also contribute to the increased PR survival observed with
hypoxia, since VEGF was found to be protective of ex vivo retinal
cultures in a model of ischemia-reperfusion injury [62], and to
reduce PR apoptosis in isolated PR cell and outer nuclear layer
explants [63]. Altogether, these findings suggest that the .60%
increase in PR survival that we observed in Tg(RHO P347S);
Edn22/2 and Pde6brd1/rd1; Edn22/2 mice in vivo may be the result,
at least in part, of retinal hypoxia and the attendant increases in
systemic EPO and intraocular VEGF.
Therapeutic implications of the common Edn2 response
in IPDs
We previously demonstrated that, like the increase in Edn2
expression in mutant PRs, a diverse set of IPDs display another
common behavior, exponential kinetics of PR death [64,65]. We
proposed that the shared kinetics suggest a commonality in the
biochemical responses of mutant PRs to a mutation. The
biochemical changes that occur downstream of a PR mutation
may converge on a relatively small number of shared pre-
apoptotic biochemical pathways that resist or mediate PR death
[65]. The increase in PR Edn2 expression in multiple models of
IPD would appear to be one such shared downstream biochemical
response. Consequently, therapies to enhance EDN2 signaling
may have potential as a general therapy for IPDs, irrespective of
the gene affected.
Other animal models of IPD must now be examined, to
determine if AAV-matEdn2 gene transfer increases mutant PR
survival in additional models, and whether the increase is greater
with less severe mutational insults than that which occurs in the
Pde6brd1/rd1 retina. In addition, tests must be undertaken to
establish that the improved PR survival seen with AAV-matEdn2
gene transfer is accompanied by conservation of vision, and that
long-term increased Edn2 expression does not have adverse effects
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on retinal function or survival. The development of general
therapies that are safe and effective in a broad range of animal
models of IPDs has important potential for patients for whom a
gene-specific therapy has not yet been developed.
Finally, our studies add to the principle, as shown with FGF2
therapy for IPDs [9,10], that augmentation of the endogenous
survival responses of mutant PRs merits on-going examination to




Animals were raised under 12-hr/light dark cycles and treated
in accordance with the guidelines and principles outlined by the
Animal Care Committee at the Hospital for Sick Children
(Toronto, ON).
Mice
Mice carrying the Pde6brd1/rd1 (C3H/HeOuJ) and Prph2rds/rds
(C3A.BLiA-Pde6b+.O20-Prph2Rd2/J) alleles, including Prph2+/+
(C3A.BLiA-Pde6b+/J) and C57BL/6J controls were obtained
from The Jackson Laboratory (Bar Harbor, ME). Prph2rds/+ mice
were generated by crossing Prph2rds/rds and Prph2+/+ mice. Tg(RHO
P347S) mice were obtained as a gift from Dr. Tiansen Li (Boston,
MA). EDN2 null mice (129Sv/Ev Taconic) were generated by
replacing part of exon 1 and all of exon 2 (corresponding to
mature EDN2), with a Neo cassette. Unflavored Peptamen (a
complete elemental nutritional supplement; Nestle, North York,
ON) was given to EDN2 mull mice to improve survival.
RNA preparation, cDNA synthesis and qRT-PCR
Total retinal RNA was extracted with Trizol (Invitrogen,
Burlington, ON) and purified using the RNeasy Mini kit (Qiagen,
Mississauga, ON) with on-column DNA digestion using the
RNase-free DNase set (Qiagen). Purified RNA was resuspended
in 30 ml RNase-free ddH2O and cDNA generated using the
Omniscript Reverse Transcription Kit (Qiagen). qRT-PCR was
performed using the ABI PrismH 7900HT sequence detection
system (Applied Biosystems, Foster City, CA), and Sequence
Detector System 2.2.1 software (Applied Biosystems) was used to
analyze the data.
HPLC, RIA and ELISA
Control peptides (EDN1, EDN2, and EDN3) were obtained
from Peptides International (Louisville, KY). Retention times and
peak areas were recorded on a tracer (BBC Goerz Metrawatt,
Sevigor 120, Markham, ON). Samples were chloroform: methanol
extracted and run through a C-2 column (GE Healthcare, QC)
before lyophilization. Isolation of EDN2 was performed using a
Zorbax SB-C18 HPLC column (5 micron, 300A˚ pore size, Agilent
technologies, Mississauga, ON) and the peptide was quantified
using an Endothelin RIA kit (RPA 555, GE Healthcare). Retinal
VEGF was assayed using the mouse VEGF Quantikine ELISA kit
(MMV00, R&D Systems, MN) and serum EPO using the Mouse/
Rat EPO Quantikine ELISA kit (MEP00, R&D Systems).
In situ hybridization, histology and immunostaining
In situ hybridization was performed using digoxygenin-labeled
riboprobes transcribed from cloned PCR products as previously
described [19]. For frozen sections, eyes were enucleated, fresh
frozen in OCT compound (Tissue-Tek, Miles, Elkhart, IN), and
10 mM sections prepared. Sections were post-fixed in 4%
paraformaldehyde (GFP) or ice-cold acetone (EDNRA, EDNRB)
and blocked with 5% normal goat serum. Sections were incubated
with rabbit anti-EDNRA (1:100, AER-001, Alomone Labs,
Jerusalem, Israel), anti-EDNRB (1:100, AER-002, Alomone Labs,
Jerusalem, Israel) or rabbit anti-GFP (1:1000, ab290, Abcam,
Cambridge, MA) followed by goat anti-rabbit secondary Alexa488
(1:500, Invitrogen).
For paraffin sections, eyes were fixed with 4% paraformalde-
hyde solution. 7 mM sections were cut and deparaffinized in
xylene. Antigen retrieval was performed with 0.05% trypsin for
15 min at 37uC (ECE-1) or incubation for 20 min at boiling in
sodium citrate buffer solution (10 mM Sodium Citrate, 0.05%
Tween 20, pH 6.0) (GS, GFAP, FGF2). Sections were either
stained with H&E or blocked with 5% normal goat serum and
incubated with anti-GS (1:5000, G2781, Sigma-Aldrich, Oakville,
ON), anti-ECE-1 (1:100, AP6855b, Abgent, Brockville, ON), anti-
GFAP (1:500, G9269, Sigma-Aldrich) or FGF2 (1:400, ab106245,
Abcam). Fluorescence was visualized with Alexa488 secondary
antibodies (1:500, Invitrogen).
For histology of retinal explants, retinas were fixed in 4%
paraformaldehyde for 2 hours at RT, embedded in OCT
compound medium (Tissue-Tek), and stained with H&E.
Retinal ONL measurements
Enucleated eyes were marked with a flamed needle to identify
the superior (dorsal) hemisphere and fixed in 2% gluteraldehyde/
0.1 M phosphate buffer. Superior and inferior globes were cut into
three equivalent parts and the rostral (superior) and caudal
(inferior) slices of the nasal quadrants embedded in Jembed 812
(Canemco, Lakefield, QC). 800 nm sections taken from nasal
rostral and caudal quadrants were cut and stained with 1%
toluidine blue. The width of the ONL was measured using
SigmaScan Pro (Systat Software Inc., San Jose, California). To
preclude variations in local retinal degeneration rates from
influencing ONL measurements, ONL thickness was determined
in orthogonal sections, by measuring thickness at a point 25% of
the distance from central to peripheral retina in Pde6brd1/rd1mice,
and at 75% of this distance in Tg(RHO P347S) retinas. The %
change in ONL thickness as indicated refers to (|M2N|/
N6100%), where N is the normal condition and M can indicate
the loss of EDN2 or introduction of the Edn2 cDNA vector.
Retinal Explants
Mice were decapitated at PN7 and retinal explants with
attached retinal pigment epithelium (RPE) were obtained as
previously described [41]. Eyes were incubated in proteinase K
solution (1.2 mg/mL) (Roche, Laval, Quebec) for 15–20 minutes
at 37uC to separate the sclera and RPE, and dissected retinas were
laid flat on Millicell-HA 0.45 mM filter membranes (Millipore,
Billera, CA). Explants were maintained under serum and
antibiotic-free conditions in R16 basal culture medium (Invitro-
gen, CA). Media was changed every two days.
AAV production and subretinal delivery
Self-complementary AAV vectors containing the small, hybrid
cytomegalovirus-chicken b-actin (smCBA) promoter driving ex-
pression of either Gfp, preproEdn2 or matEdn2 were generated and
purified by previously described methods [66]. Vector titer was
determined by qRT-PCR and final aliquots were resuspended in
balanced salt solution (Alcon Laboratories, Forth Worth TX,
USA) containing 0.014% Tween 20. qRT-PCR expression of the
AAV-specific Edn2 mRNA was measured using a 39primer specific
to the 39 tail of the mRNA, including the polyA sequence.
For subretinal injections, mice were anaesthetized with keta-
mine/xylazine (IP, 150 mg/kg ketamine, 10 mg/kg xylazine) and
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the cornea punctured with a 30-gauge needle between the
corneoscleral junction and the ora serrata. A 33-gauge blunt
needle attached to a 10 ml Hamilton syringe (Hamilton Company,
Reno, NV) was used to dispense 1 ml of fluid (viral titre 1–
561012 VG/mL) containing 0.1 mg/mL fluorescein (Alcon,
Mississauga, ON) to aid visualization of the subretinal injection
site. Mice were treated with topical tropicamide ointment (Alcon)
following injection and administered 300 ml normal saline S.C. to
prevent dehydration.
Microarrays
For microarray studies, retinas were homogenized in GIT
buffer (4 M guanidine isothiocyanate, 25 mM sodium acetate
(pH 6), 120 mM b-mercaptoethanol). Total RNA was further
isolated by cesium chloride density gradient centrifugation and
purified using the RNeasy Mini kit (Qiagen). RNA quality was
assessed using a Bioanalyzer (Agilent Technologies, Mississauga,
ON). Briefly, labeled cRNA was hybridized to the Mouse 430_2.0
Array representing over 39,000 mouse transcripts and probe
sequences from GenBankH, dbEST, and RefSeq (Affymetrix,
Santa Clara, CA). Affymetrix Gene Chip Operating Software
(GCOS) was then used to generate.cel microarray files which were
further analyzed using Robust Multi-chip Averaging (RMA)
algorithms (Affymetrix). Significance analysis was performed using
the Significance Analysis of Microarrays program (SAM, Stanford
University Labs) [67], and a list of differentially expressed genes
generated. For the Edn2+/+ vs. Tg(RHO P347S) Edn2+/+ and
Edn22/2 vs. Tg(RHO P347S) Edn22/2 comparisons, an FDR of
5% was used, whereas for the Edn2+/+ vs. Edn22/2 analysis, an
FDR of 25% was used (NCBI GEO Accession GSE38797).
Supporting Information
Figure S1 Quantification of mRNA expression of Edn1,
Edn3, EdnrA and EdnrB in mouse retinas. qRT-PCR was
used to quantify the expression of Edn1, Edn3, EdnrA and EdnrB in
Tg(RHO P347S) retinas in the presence and absence of EDN2
function. Bar graphs show the expression of mRNAs in retinas of
the indicated genotypes relative to the expression levels seen in
Edn2+/+ (WT) retinas (arbitrarily assigned a value of 1). There
were no significant differences in expression except for a slight
increase in the EdnrA mRNA in Tg(RHO P347S);Edn22/2 vs.
Edn2+/+ retinas (*n = 3, p,0.05) (n = 3;p.0.05 for all other
comparisons). All qRT-PCR values were normalized to Gapdh
mRNA.
(TIF)
Figure S2 Immunostaining of ECE-1, EDNRA and
EDNRB in mouse retinas. (A) The localization of ECE-1
immunofluorescence in WT retina overlaps that of the Mu¨ller cell
marker glutamine synthetase. ECE-1 expression was observed in
both Mu¨ller cell extensions and cell bodies. (B) Immunofluores-
cence localization of EDNRA and EDNRB in mouse retinas.
EDNRA staining was sporadically observed in the GCL, INL,
OPL and choroid plexus, irrespective of genotype. Although
EDNRA staining in choroid, GCL and OPL is indicative of vessels
[26], EDNRA expression in the INL and ONL of Pde6brd1/rd1;
Edn22/2 retinas may represent retinal microglia (42), which
migrate to the mutant PRs in the ONL [39]. EDNRB
immunoreactivity was predominantly observed in Mu¨ller cell
radial fibres and in the OPL and GCL, possibly representing
horizontal cells and astrocytes, respectively [25]. In the Pde6brd1/rd1
retina, EDNRB expression was significantly increased in Mu¨ller
cell radial fibres, with stronger staining in the inner limiting
membrane; this stronger staining may correspond to the end feet
of Mu¨ller cells as well as astrocytes [69]. OLM, outer limiting
membrane; ONL, outer nuclear layer; OPL, outer plexiform layer;
INL, inner nuclear layer; GCL, ganglion cell layer; ILM, inner
limiting membrane. (Bar = 25 mm).
(TIF)
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